4.7 Review

Recent Endovascular Stroke Trials and Their Impact on Stroke Systems of Care

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 67, 期 22, 页码 2645-2655

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2015.12.077

关键词

acute ischemic stroke; endovascular therapy; randomized clinical trials; stroke centers; thrombectomy

资金

  1. Toshiba
  2. Apama
  3. Augmenix
  4. Axtria
  5. Boston Scientific
  6. Claret Medical Inc.
  7. Ellipse
  8. Endomation
  9. Medina Medical
  10. NextPlain
  11. Ostial Corporation
  12. Photolitec
  13. Silk Road
  14. StimSox
  15. ValenTx
  16. Valor Medical
  17. Abbott for carotid training for physicians
  18. National Institutes of Health/National Institute of Neurological Disorders
  19. Stroke/National Institute of Biomedical Imaging and Bioengineering and University at Buffalo
  20. Hotspur
  21. Intratech Medical
  22. Blockade Medical
  23. Lazarus Effect
  24. Abbott Vascular
  25. Cordis
  26. EndoTex
  27. EPI
  28. ev3
  29. Guidant
  30. Kerberos
  31. Medtronic
  32. Micrus
  33. Zimmer
  34. Access Closure Inc.
  35. Primus

向作者/读者索取更多资源

Five recently published randomized trials of endovascular therapy versus medical management, including intravenous thrombolysis, demonstrated strong positive data in support of intra-arterial thrombectomy procedures. The American Heart Association/American Stroke Association released a focused update of the 2013 guidelines on the early management of acute ischemic strokes to specifically incorporate the findings of the 5 positive trials. In this review, we examine the key results of those trials and the principal changes in the updated guidelines. We discuss the ongoing and future changes in stroke systems of care, with an emphasis on the role of pre-hospital stroke triage, interhospital transfer, and the 2 main levels of stroke center certification (primary and comprehensive). (C) 2016 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据